Skip to main content
Podcast microphone headphones
Podcast microphone headphones
Podcast microphone headphones
Podcast microphone headphones
Day 4: ACR 2019 Podcast
Podcast microphone headphones
Day 3: ACR 2019 Podcast
Podcast microphone headphones
Day 2 (part two) ACR 2019 Podcast
Podcast microphone headphones
Day 2 (part one) Podcast
Podcast microphone headphones
ACR Posters
ACR 2019 - Report from Day 3 (Tuesday)
Jack Cush, MD
Here's my summary of key studies presented Tuesday.  Tofacitinib in Polyarticular JIA
iv infusion hospital drip
Rheumatic immune-related adverse events can start at almost any time after the commencement after immune checkpoint inhibitor immunotherapy for cancer, and are liable to persist long after the immunotherapy has ceased, according to data presented at ACR 2019 in Atlanta, Georgia.
Smile frown emoticon happy sad
The Medscape’s Physician Lifestyle & Happiness Report 2019 crowned rheumatologists as the happiest subspecialists. We topped the list with 65% of the respondents indicating that they were happy outside of work. I was not really surprised by reading that, and I would go as far as saying that our
neon question mark
At the 2019 ACR Annual Meeting in Atlanta, almost 500 presentations discussed new randomized controlled trials (RCTs). We are lucky to have so much research activity in our field, but applying an RCT to your daily practice can be challenging. Here are three tips to supercharge your critical
vasculitis open hand
Flares of vasculitis can still be a problem after hepatitis C-related cryoglobulinemic vasculitis patients are cured of their hepatitis C by direct-acting antivirals, as demonstrated by data from four registries presented at ACR 2019 in Atlanta, Georgia.
vaccine shot
Herpes Zoster Vaccine Update
Cassandra Calabrese, DO
Shingrix (GSK), the herpes zoster subunit vaccine (a two-shot series), was approved by the FDA in Fall 2018 and is currently approved for use in adults 50 years and older.
needle haystack rare
Autoinflammatory Diseases at the ACR Annual Meeting
Jonathan Hausmann, MD
It has been a wonderful year for autoinflammatory diseases at the ACR Annual Meeting. I attended my first ACR Annual Meeting in 2011 in Chicago. In that meeting, there were 29 abstracts on autoinflammatory diseases and there were no sessions exclusively focusing on that topic*.
sunset bench exercise
Muscle Loss and Frailty in Rheumatic Disease
Paul Sufka, MD
“If exercise could be purchased in a pill, it would be the single most widely prescribed and beneficial medicine in the nation.” —Robert H. Butler, MD, first director of the National Institute on Aging.
Systemic JIA-associated Lung Disease
Jonathan Hausmann, MD
A disease you’ve never heard of is becoming increasingly common and carries a very poor prognosis. 
Capitol washington congress
2021 E/M Coding Update
Rachel Tate, DO
As a rheumatologist, I pride myself on being an advocate for my patients, but I'm not always an advocate for my profession or myself. Should rheumatologists be involved in policy? Should we be political? 
ACR Session 2
ACR 2019 - Report from Day 2 (Monday)
Jack Cush, MD
Monday was another full day of sessions and studies here in Atlanta. Following is my roundup of day two. The Safety of Methotrexate
foot pain gout
Therapies targeting sUA accumulation or improving its excretion are widely used for treatment of symptoms and prevention of progression of gout for decades. Despite our best effort, there is still significant amount of patients who remain symptomatic and/or experiences progressive joint damage and
light bulb thought
ACR 2019 - Report from Day One (Sunday)
Jack Cush, MD
Sunday was the first full day of scientific sessions at the 2019 ACR/ARP meeting in Atlanta. Yesterday we shared our initial news articles, videos and more with you. Following is my roundup of day one.  Delays in Diagnosis
Polymyalgia rheumatica (PMR) is a common condition seen by both primary care and in the rheumatology office.
A Focus on WOCBA (Women of Childbearing Age)
Maeve Gamble, MD
Many rheumatic diseases affect women of childbearing age. In the age of biologic therapy, women are achieving better disease activity and there are increasing numbers of women with rheumatic diseases attempting pregnancy. 
xray spine
IL-17 inhibitors in non-radiographic axial SpA
Philip Robinson, MD
This meeting sees new data on using anti-IL-17 agents in non-radiographic axial SpA. Up until now these patients have only had TNF inhibitors available, so data about the efficacy of IL17 inhibitors is really important.
The ACR 2019 Playbook
Jack Cush, MD
The annual ACR/ARP meeting will begin today, Sunday. For many this is the premier meeting in rheumatology. For the ACR it is their biggest educational event. It's also big for industry, academics, North American and international rheumatologists and especially important to those who will be
Gout is a systemic inflammatory disease with high potential for joint damage due to erosive changes and MSU deposits resulting in disability and chronic pain. Prompt diagnosis and effective treatment are key to better long term outcomes and decreased disability.
Checkpoint inhibitors
Rheumatic Manifestations of Cancer Immunotherapies
Antoni Chan, MD, PhD
One area I am very interested to learn more about at #ACR19 are the rheumatic manifestations of cancer immunotherapies. In the last 5 years, there has been an expansion of the use of immune checkpoint inhibitor (CPIs) therapy in cancer. The number of patients treated with CPIs is predicted to
I have been attending the ACR Review Course for more than a decade, and it seems every year it gets better and better. Contrary to what most people think, this is not a board review course; it is more of a review of the latest research delivered by experts condensing rheumatology in eight hours.
RA rheumatoid hands
This ACR has seen some more great work on tapering of therapy in rheumatoid arthritis. It’s a hot topic and one which I get asked about all the time by my patients.
twitter bird
Should we all be Tweetiatricians?
Maeve Gamble, MD
I’m excited to participate as a RheumNow reporter at this year’s ACR.  As we head into the conference, I reflect on the role Twitter will have this week and on a larger scale, the role of social media in medicine. 
flu sick
Influenza Vaccine Updates and Pearls at ACR 2019
Cassandra Calabrese, DO
As we enter flu season it is of the utmost importance that we remember to assess our patients’ influenza vaccine status at each visit.
There are proportionately more male than female physicians across most medical specialties in Canada and the U.S. despite the current gender parity in medical school.
Arrow diverge
When Classification and Diagnosis Diverge
Michael Putman, MD
Like many rheumatologists who are headed to the 2019 American College of Rheumatology meeting in Atlanta, I am eagerly looking forward to learning about the new criteria in vasculitis, lupus, and autoinflammatory recurrent fevers. Yet conference attendees should remember that these criteria are
Atlanta Falcon Statue
Gearing up for ACR
Rachel Tate, DO
ACR is a whirlwind!  It’s akin to the “drinking from the firehose” analogy from medical school. Here are a few simple ideas to keep your head from swimming and to make learning fun and easy.